Single nucleotide polymorphism (SNP) genotyping is the measurement of genetic variations between members of a species. A SNP is a single base pair mutation at a specific locus, usually consisting of two alleles (where the rare allele frequency is > 1%). SNPs are found to be involved in the etiology of many human diseases and are becoming of particular interest in pharmacogenetics. SNPs can also provide a genetic fingerprint for use in identity testing. The increase in interest in SNPs has been reflected by the furious development of a diverse range of SNP genotyping methods.
The global single nucleotide polymorphism genotyping market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global single nucleotide polymorphism genotyping market segmentation is based on technologies (AB SNPlex, MassARRAY MALDI-TOF, SNP by Pyrosequencing, SNP GeneChips and Microarrays, Taqman Allelic Discrimination, and applications (agricultural biotechnology, breeding and animal livestock, diagnostic research, pharmaceuticals and pharmacogenomics).
The global single nucleotide polymorphism genotyping market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global single nucleotide polymorphism genotyping market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global single nucleotide polymorphism genotyping market and included in this report are Affymetrix, Inc., Douglas Scientific LLC, Fluidigm, Illumina, Inc., Life Technologies Corporation, PREMIER Biosoft, ThermoFisher Scientific, and Sequenom, Inc.